Palsonify Logo

Now FDA Approved

GO TO PALSONIFY.COM
Palsonify Logo

Now FDA Approved

GO TO PALSONIFY.COM

News & Events

Show:
November 2, 2015

The San Diego Union-Tribune: Crinetics raises $40 Million

November 2, 2015 — Seeking to get its first drug ready for human testing, San Diego biotech Crinetics Pharmaceuticals has...

READ MORE
November 2, 2015

Crinetics Pharmaceuticals Completes $40 Million Series A Financing

SAN DIEGO – November 2, 2015 – Crinetics Pharmaceuticals, an innovative therapeutics company focused on specialty endocrine disorders, announced today...

READ MORE
April 27, 2015

Crinetics Pharmaceuticals Appoints Matt Fust, M.B.A., David Clemons, M.D., and John Wallen, Ph.D., J.D. as Corporate, Clinical, and Legal Advisers

SAN DIEGO – April 27, 2015 – Crinetics Pharmaceuticals (“Crinetics”), an innovative therapeutics company focused on endocrine diseases and cancers,...

READ MORE
April 27, 2015

Crinetics Pharmaceuticals Awarded NIH Fast-Track Grant to Develop Somatostatin Receptor Agonist Drugs for Chronic Pain

SAN DIEGO – April 27, 2015 – Crinetics Pharmaceuticals (“Crinetics”), an innovative therapeutics company focused on endocrine diseases and cancers,...

READ MORE
January 28, 2015

Crinetics Pharmaceuticals Awarded $1.5MM NIH Phase-II SBIR Grant to Develop Kisspeptin Receptor Antagonists for PCOS and Other Women’s Health Diseases

SAN DIEGO — January 28, 2015 — San Diego-based Crinetics Pharmaceuticals announced today that it has been awarded a $1.5...

READ MORE
April 28, 2014

Crinetics Pharmaceuticals Awarded NIH Phase-I SBIR Grant to Develop Somatostatin Receptor Agonist Drugs for Ophthalmic Diseases

SAN DIEGO — April 28, 2014 — San Diego-based Crinetics Pharmaceuticals announced today that it has been awarded a Phase...

READ MORE
September 13, 2013

Crinetics Pharmaceuticals Awarded NIH Phase-II SBIR Grant to Develop Drugs for Pituitary Tumors

SAN DIEGO — September 3, 2013 — San Diego-based Crinetics Pharmaceuticals announced today that it has been awarded a $2.2MM...

READ MORE
February 7, 2009

Crinetics Pharmaceuticals Awarded National Institutes of Health Small Business Innovative Research Grant to Develop GPCR Biosensors for Drug Discovery

Crinetics Pharmaceuticals announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the...

READ MORE